University of Maryland School of Medicine logo
Center for International Health, Education, and Biosecurity
All Departments
UMSOM Assistant
2025 Impact Stories
  • Home
  • Ciheb
  • Impact Stories
  • 2025 Impact Stories
  • Impact Stories
  • 2026 Impact Stories
  • 2025 Impact Stories
  • 2024 Impact Stories
  • 2023 Impact Stories
  • 2022 Impact Stories
  • 2021 Impact Stories
  • 2020 and Older

Ciheb at the International AIDS Symposium 2025

CihebImpact Stories2025 Impact StoriesCiheb at the International AIDS Symposium 2025

August 01, 2025

KIGALI – CIHEB participated in the International AIDS Society (IAS) Conference on HIV Science, held from July 13–17, 2025, under the theme “Confronting the Storm: The Future of the HIV Response.”

The conference featured key contributions from experts across the field, including Linah Mwango, who presented findings on the real-world implementation of long-acting cabotegravir (CAB-LA) for HIV prevention in Zambia.

Mwango spoke during the panel “The Future of Person-Centred HIV Prevention: Latest Evidence from the African Continent.” The session highlighted innovative HIV prevention strategies, emphasizing the role of long-acting prevention medicines and the importance of aligning innovation with person-centered care to sustain progress against HIV in Africa.

In collaboration with Kristen Stoebenau, Mwangala Mwale, Godfrey Muchanga, Choolwe Maambo, Chipe Geaty, Kathryn Macdonald, Caitlin Baumhart, Obvious Chilyabanyama, Natalia Blanco, Lloyd Mulenga, Cassiday Classen, and Marie-Claude Lavoie, Mwango presented promising research on the implementation of CAB-LA among adolescent girls and young women (AGYW) in Zambia. This work, conducted within a community-based model as part of the Determined, Resilient, Empowered, AIDS-Free, Mentored, and Safe (DREAMS) program, examined how CAB-LA can be integrated into holistic HIV prevention efforts.

DREAMS aims to build resilience, support education, foster healthy relationships, and expand access to essential health services for AGYW—empowering them to lead healthy, AIDS-free lives. Key findings from the research included:

  • Themes were analyzed using the Andersen Healthcare Utilization Model, which considers the external environment, predisposing characteristics, enabling factors (facilitators and barriers), and perceived needs that influence health service use.

  • Participants reported high satisfaction with CAB-LA and minimal side effects.

  • All participants (100%) returned on schedule for their second CAB-LA dose.

IAS offers a chance for engagement with other organizations and experts, exchanging knowledge and exploring potential collaborations. The symposium, an annual gathering of global experts in the field of HIV/AIDS, showcased more than 140 oral abstract sessions, 1,400 posters, and 600 speaker sessions. Next year’s IAS 2026 will take place in Rio de Janeiro, Brazil, in July 2026.

Contact

Jennifer Gonzales
Jennifer.gonzales@ihv.umaryland.edu

University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map